Now available on MDLinx Urology, find daily updates summarizing the top literature from over 2,000 peer-reviewed journals, including Journal of Urology, European Urology, The Prostate, and more. Find coverage of the kidney, bladder, penis/urethra and prostate. View article summaries by subspecialty and disease state, including peds urology, urologic oncology, stone disease, infections and STDs, urologic imaging, ureteral disease, voiding and incontinence, infertility, laparoscopy and other surgical techniques, and additional hot topics in your field. Find exclusive content only available on MDLinx Urology like articles highlighted by physician editor D. Scott Cunningham, MD, PhD, and clinical pearls gleaned from The Smartest Doc quiz competitions and Physician Reviews.
Your Unread Messages in Urology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Delay in referral for abnormal PSA associated with disease progression
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Urologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACAG) in patients with locally advanced carcinoma of the bladder Urology, May 24, 2013 Clinical Article
2 NF-kappaB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants Molecular Cancer Therapeutics, May 24, 2013 Clinical Article
3 Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study The Lancet Oncology, May 23, 2013 Clinical Article
4 Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines Journal of Andrology, May 22, 2013 Clinical Article
5 Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma Acta Oncologica, May 22, 2013 Clinical Article
6 Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer Expert Opinion on Investigational Drugs, May 21, 2013 Review Article
7 Current pharmacological treatment options for male lower urinary tract symptoms Expert Opinion on Pharmacotherapy, May 21, 2013 Clinical Article
8 Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism Cancer Research, May 20, 2013 Clinical Article
9 Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results American Journal of Transplantation, May 20, 2013 Clinical Article
10 A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases Clinical Cancer Research, May 17, 2013 Clinical Article
11 Prescription Opioids for Back Pain and Use of Medications for Erectile Dysfunction Spine, May 17, 2013 Evidence Based Medicine Clinical Article
12 Cephalothin susceptibility testing as class representative for oral cephalosporins: is it time to move on Diagnostic Microbiology and Infectious Disease, May 17, 2013 Clinical Article
13 A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy The Journal of Urology, May 16, 2013 Clinical Article
14 Evaluation of Mycophenolic Acid Exposure Using a Limited Sampling Strategy in Renal Transplant Recipients American Journal of Nephrology, May 15, 2013 Clinical Article
15 Basiliximab induction in renal transplantation: Long-term outcome Full Text Saudi Journal of Kidney Diseases and Transplantation, May 14, 2013 Clinical Article
16 Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable MR-US registration system BJU International, May 13, 2013 Clinical Article
17 Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing The Journal of Urology, May 13, 2013 Review Article
18 Intraurethral tramadol alleviates rigid cystoscopy-related pain in men International Journal of Urological Nursing, May 13, 2013 Clinical Article
19 A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer Investigational New Drugs, May 7, 2013 Clinical Article
20 Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer Clinical Cancer Research, May 7, 2013 Clinical Article
Researchers at the University of Southern California have reported a risk between advanced cancer of the prostate and red meats cooked at high temperature, pan-frying, and prepared "well done." The study involved 1140 men with advanced cancer of the prostate, 717 men with localized cancer of the prostate, and 1096 healthy controls from the California Collaborative Prostate Cancer Study. There was an inverse association between baked poultry and advanced prostate cancer.
Read the article summaryResearchers at the University of Chicago Pritzker School of Medicine have reported that older age and the pre-operative MMSE results are associated with post-radical cystectomy (OR = 1.52) in patients > 65 years of age (n=49). The incidence of post-operative delirium was 29%. Further, patients with post-operative delirium were at increased risk for readmission (OR = 10.7) and re-operation (OR = 9.2).
Read the article summaryAs published in European Neurology, men (age range, 55-69 years) who undergo PSA screening are at decreased risk for metastatic cancer of the prostate. The study involved 76,813 men with a median follow-up of 12 y. There were 666 cases with metastatic cancer of the prostate(256 screened [.67%/1000] and 410 non-screened [.86%/1000]). The HR for men who were screened was 0.58.
Read the article summary1 Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study British Medical Journal, April 23, 2013
2 Balanitis xerotica obliterans, the topical application of tacrolimus ointment, and the result: an institutional study UroToday International Journal, April 15, 2013
3 Results of a randomized phase III trial of mirabegron in patients with overactive bladder The Journal of Urology, April 8, 2013
4 Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study Prostate Cancer & Prostatic Diseases, April 11, 2013
5 Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention Urology, April 9, 2013
6 STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma European Urology, April 5, 2013 Free full text
7 Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer Annual Review of Medicine, April 26, 2013 Review Article
8 Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-t in the immunotherapy for prostate adenocarcinoma treatment (impact) trial Urology, April 12, 2013
9 Simvastatin induces apoptosis in castrate resistant prostate cancer cells by deregulating nuclear factor-κb pathway The Journal of Urology, April 12, 2013
10 Amphotericin B bladder irrigation for the treatment of neonatal bladder fungus ball Journal of Pediatric Infectious Diseases, April 15, 2013
11 A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer Cancer Chemotherapy and Pharmacology, April 22, 2013
12 Peironimev-Plus in the Treatment of Chronic Inflammation of Tunica Albuginea (Peyronies Disease). Results of a Controlled Study Inflammation & Allergy - Drug Targets, April 9, 2013
13 Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial Urologic Oncology: Seminars and Original Investigations, March 26, 2013
14 Prevalence of patients with nonmetastatic prostate cancer on androgen deprivation therapy in the United States Urology, April 19, 2013
15 Botulinum toxin-A for the treatment of overactive bladder: UK contributions Journal of Clinical Urology, April 10, 2013
16 Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis Urological Research - Urolithiasis, April 2, 2013
17 A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases Clinical Cancer Research, April 4, 2013
18 Randomized controlled trial to assess the efficacy of the combination therapy of alfuzosin and tadalafil in patients with lower urinary tract symptoms due to benign prostatic hyperplasia LUTS: Lower Urinary Tract Symptoms, April 5, 2013
19 Does tamsulosin change the management of proximally located ureteral stones? Urological Research - Urolithiasis, March 1, 2010
20 Urolithiasis in patients on high dose felbamate The Journal of Urology, April 16, 2013 Review Article
Indexed Journals in Urology: Urology, Journal of Urology, European Urology, The Prostate more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close